Skip to content

GECo: Implementation and Effectiveness of COPD Self Management Action Plans in Low and Middle Income Countries

Global Excellence in COPD Outcomes: Implementation and Effectiveness of COPD Self-Management Action Plans in Low and Middle Income Countries

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03359915
Acronym
GECo2
Enrollment
240
Registered
2017-12-02
Start date
2017-12-31
Completion date
2020-02-29
Last updated
2017-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD, Self-Management, Action Plan, SGRQ, LMIC, COPD Diagnosis

Brief summary

This study will randomise people with clinically significant COPD (GOLD Grade B-D) to usual care or provision of a self-management action plan supported by monthly follow-up visits from a community health worker trained in the use of the action plan. The primary outcome will be health-status: a comparison of the change in St. George's Respiratory Questionnaire (SGRQ) between baseline and 12 months in the two groups. We will randomise 240 people from three low- and middle-income countries, namely Nepal, Peru and Uganda. We will also examine the feasibility of implementing our self-management action plan intervention at scale.

Detailed description

The investigators will determine whether a self-directed COPD Action Plan for the management of COPD exacerbations can be implemented with trained community health workers (CHWs). The investigators hypothesise that COPD action plans with disease-specific education and support from a CHW will lead to improved quality of life and will be locally-appropriate, acceptable, and feasible to implement. 1. Clinical Aim 1: Assess the clinical effectiveness of CHW-supported COPD Action Plans in LMICs by comparing change in disease-specific quality of life measures (SGRQ) at one year. 2. Implementation Aim 1: Assess the appropriateness, acceptability, and feasibility of implementing a CHW-supported, self-directed COPD Action Plan for management of COPD exacerbations. The investigators will also determine whether a CHW-supported, self-directed COPD Action Plan is cost-effective, accounting for implementation realities. We hypothesise that COPD Action Plans are a cost-effective intervention, as measured by the incremental QALY. 1. Clinical Aim 2: Assess the cost-effectiveness of COPD Action Plans in terms of health-related costs and health benefits and explore broader cost implications to productivity. 2. Implementation Aim 2: Explore how the value of the COPD Action Plans is affected by both implementation factors that restrict optimal provision ('constraints') and sub-group differences, which have implications for equity. The final design of our intervention will be informed by formative work prior to commencement of the main study. Study fieldworkers will enroll and randomise 80 adults aged ≥40 years with GOLD GRADE B-D COPD at each of the following three countries in the catchment areas of existing community census areas in Bhaktapur (Nepal), Lima (Peru), and Nakaseke (Uganda). They will then be randomised via an online system into either a control (usual care) or intervention group. The intervention arm will receive a specific self-management plan for COPD facilitated by trained CHWs, who will then visit the participants monthly. The control group will receive basic COPD education and be reminded about the sites for their local health care providers. The primary effectiveness outcome for the study will be change in health-status (SGRQ) between baseline and 12 months, across the two groups. We will also examine the cost-effectiveness of self-management for individuals with COPD. The investigators will also examine the feasibility of implementing our self-management action plan intervention at scale.

Interventions

BEHAVIORALCOPD Self-Management Plan

Patient education in use of a COPD self-management action plan supported by monthly visits from, and access to, a CHW who has been trained in the use of a COPD self-management action plan.

Sponsors

Johns Hopkins University
CollaboratorOTHER
Universidad Peruana Cayetano Heredia
CollaboratorOTHER
Asociacion Benefica Prisma
CollaboratorOTHER
Makerere University
CollaboratorOTHER
University of York
CollaboratorOTHER
Institute of Medicine, Tribhuvan University, Nepal
CollaboratorUNKNOWN
University College, London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

RCT Phase - Parallel Groups: 240 in total Control arm - 120 participants Intervention Arm - 120 participants

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male or female participants aged ≥40 years * Full-time resident in the area (living in area \> 6 months) * Able to perform adequate quality spirometry * Capable of providing informed consent * Identified as having COPD grade B-D as per GOLD criteria

Exclusion criteria

* Pregnancy (self-reported) * Currently has active pulmonary TB or is taking medications for pulmonary TB * Identified as having COPD grade A as per GOLD criteria

Design outcomes

Primary

MeasureTime frameDescription
Change in SGRQ12 monthsComparison of the change in SGRQ between baseline and 12 months, in the intervention compared to the control arm. b) Implementation Aim 1: Assess the appropriateness, acceptability and feasibility of using questionnaires and PEF to identify COPD cases from the perspective of local community members, community health workers, local health centre physicians and ministries of health.

Secondary

MeasureTime frameDescription
Number of Exacerbations12 monthsComparison of the number of COPD exacerbations in 12 months, between the intervention compared to the control arm.
Number of Hospitalisations12 monthsComparison of the number of hospitalisations in 12 months, between the intervention compared to the control arm.
Number of CHW visits12 monthsComparison of the number of CHW visits in 12 months, between the intervention compared to the control arm.
Health-Economics12 monthsAssess the cost-effectiveness of a supported COPD Action Plan in terms of health-related costs and health benefits and explore broader cost implications to productivity.

Countries

Nepal, Peru, Uganda

Contacts

Primary ContactJohn R Hurst, FRCP, PhD
j.hurst@ucl.ac.uk+442074726260
Backup ContactWilliam Checkley, MD, PhD
wcheckl1@jhmi.edu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026